期刊文献+

腹膜透析生存率及其预后分析 被引量:12

Survival Probability and Multivariate Analysis of Prognostic Factors in Continuous Ambulatory Peritoneal Dialysis Patients
下载PDF
导出
摘要 目的 :调查腹膜透析病人的生存率及其独立的预后因素 ,识别病人死亡的高危人群 ,以指导临床治疗。方法 :随诊腹膜透析病人 2 6 8例 ,采用Kaplan -Meirie法分析生存率 ,采用COX模型多变量分析透析前各临床指标对预后的影响。结果 :2 6 8例病人中位数随访时间为 2 6个月 ;1年、2年、3年及 4年总体生存率分别为 85 .6 %、6 7.1%、5 6 .9%及 44 .4% ;经时序检验 ,透析前病人年龄、体重、经济状况、残余尿量、原发病、合并疾病、血红蛋白、血清白蛋白、血清尿素氮、肌酐及血磷浓度对生存率均有影响 (P值均 <0 .0 5 ) ;经COX回归分析 ,透析前病人年龄、血清白蛋白及合并疾病成为独立的预后因素。结论 :我国腹膜透析远期生存率稍低于西方发达国家。根据透析前年龄、血清白蛋白及有无合并疾病 。 Objective: To identify risk factors influencing survival in continuous ambulatory peritoneal dialysis (CAPD) patients. Methods: 268 cases of CAPD patients were followed. Survival probability was studied with Kaplan-Meier method and clinical prognostic factors were analyzed with the Cox Proportional Hazards model. Results: The median follow-up duration was 26 months. The overall survival probability at 1, 2, 3 and 4 year was 85.6%, 67.1%, 56.9% and 44.4% respectively. Patients with age>55, weight<50 kg, poor economic status, residual urine volumes<500 ml/d, having comorbidities, hemoglobin<60 g/L, serum albumin<33 g/L, blood urea<35.7 mmol/L, serum creatinine<800 μmol/L, and serum phosphate<2.5 mmol/L had lower survival probabilities. Cox regression showed age, serum albumin and comorbidities were independent prognostic predictors. Conclusion: Long-term survival probabilities of CAPD patients in China are slightly lower than those in western developed countries. The prognosis of patients can be preliminarily analyzed based on their ages, serum albumin and comorbidities before initiation of dialysis.
出处 《中国中西医结合肾病杂志》 2002年第2期82-84,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 卫生部临床学科重点项目基金资助 (No .970 40 2 2 8)
关键词 持续不卧床腹膜透析 预后 COX模型 血液透析 生存率 CAPD Peritoneal dialysis Prognosis Hemodialysis
  • 相关文献

参考文献10

  • 1叶任高,陆才生.要加强腹膜透析的研究[J].中华肾脏病杂志,1997,13(5):259-261. 被引量:56
  • 2李士梅 叶任高 李惠群 等.不卧床持续腹膜透析治疗慢性肾功能衰竭[J].中华内科杂志,1981,20:323-325.
  • 3骆福添.生存分析.见:方积乾.医学统计学与电脑实验.上海:上海科技出版社,1995.332-349.
  • 4Cancarini GC, Brunori G, Zani R, et al. Long-term outcomes of peritonea l dialysis. Perit Dial Int,1997,17(suppl 2):115-118.
  • 5Gamba G, Mejia JL, Saldivar S, et al. Death risk in CAPD patients. Neph ron,1993,65:23-27.
  • 6Davies SJ, Russell L, Bryan J, et al. Comorbidity, urea kinetics, and a ppetite, in CAPDS patients, their interrelationship and predication of survival. Am J Kidey Dis,1995,26(2): 353-361.
  • 7Churchill D, Jaylor D, Keshaviahp, et al. Adequacy of dialysis and nutr ition in continous peritoneal dialysis: Association with clinical outcome. J Am Soc Nephrol,1996,7:198-207.
  • 8Nossent HC, Swaak TJG, Berden JOHM, et al. Systemic lupus erythematos us: Analysis of disease activity in 55 patients with end-stage renal failure tre ated with hemodialysis or continous ambulatory peritoneal dialysis. Am J Med,199 0,89:169-174.
  • 9Klefter R, Lokkegaard H. Risk factors in CAPD patients. Perit Dial Int, 1997,17(1):98.
  • 10.Lowrie EG, Lew NL. Death risk in hemadialysis patients: the predictive value of commonly measared variables and evaluation of death rate differences b etween facilities. Am J kidney Dis,1990,15:458-482.

共引文献55

同被引文献71

引证文献12

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部